Louise Hecker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Louise Hecker has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Victor J. Thannickal
Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, The University of Alabama at Birmingham, Birmingham, USA
2 shared publications- Victor J. Thannickal
Tulane University School of Medicine
2 shared publications Ashish Kurundkar
Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA
1 shared publicationDeepali Kurundkar
Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA
1 shared publicationEric Meldrum
Genkyotex, 1228 Geneva, Switzerland
1 shared publicationJeff Cheng
Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, The University of Alabama at Birmingham, Birmingham, USA
1 shared publication
Latest Publications
- Top Cited Papers
- 9 April 2014
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 6 (231) , 231ra47
Reversal of Persistent Fibrosis in Aging by Targeting Nox4-Nrf2 Redox Imbalance
Fibrosis resolution is impaired by aging and is mediated by altered cellular redox homeostasis because of a Nox4-Nrf2 imbalance that promotes an apoptosis-resistant myofibroblast phenotype.
- 9 April 2014
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 6 (231) , 231ra47
Top Cited PapersReversal of Persistent Fibrosis in Aging by Targeting Nox4-Nrf2 Redox Imbalance
Fibrosis resolution is impaired by aging and is mediated by altered cellular redox homeostasis because of a Nox4-Nrf2 imbalance that promotes an apoptosis-resistant myofibroblast phenotype.
- 23 May 2012
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 69 (14) , 2365-2371
Targeting NOX enzymes in pulmonary fibrosis
Oxidative stress has been associated with a number of human fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). Oxidative stress is most often defined as an imbalance between the generation of reactive oxygen species (ROS) in excess of the capacity of cells/tissues to detoxify or scavenge them. Additionally, the regulated production of ROS participates in cellular signaling. Therapeutic strategies to treat IPF have, thus far, focused on augmenting anti-oxidant capacity. Recent studies have demonstrated a critical role for ROS-generating enzymatic systems, specifically, NADPH oxidase (NOX) family oxidoreductases in fibrotic processes. In this review, we examine the evidence for NOX isoforms in the generation and perpetuation of fibrosis, and the potential to target this gene family for the treatment of IPF and related fibrotic disorders.
- 23 May 2012
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 69 (14) , 2365-2371
Targeting NOX enzymes in pulmonary fibrosis
Oxidative stress has been associated with a number of human fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). Oxidative stress is most often defined as an imbalance between the generation of reactive oxygen species (ROS) in excess of the capacity of cells/tissues to detoxify or scavenge them. Additionally, the regulated production of ROS participates in cellular signaling. Therapeutic strategies to treat IPF have, thus far, focused on augmenting anti-oxidant capacity. Recent studies have demonstrated a critical role for ROS-generating enzymatic systems, specifically, NADPH oxidase (NOX) family oxidoreductases in fibrotic processes. In this review, we examine the evidence for NOX isoforms in the generation and perpetuation of fibrosis, and the potential to target this gene family for the treatment of IPF and related fibrotic disorders.
- 1 June 2011
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 341 (6) , 431-434
Nonresolving Fibrotic Disorders: Idiopathic Pulmonary Fibrosis as a Paradigm of Impaired Tissue Regeneration
- 1 June 2011
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 341 (6) , 431-434
Nonresolving Fibrotic Disorders: Idiopathic Pulmonary Fibrosis as a Paradigm of Impaired Tissue Regeneration
- 20 August 2010
- Published by Springer Nature
- p. 425-441
Oxidative Stress and Cardiovascular Fibrosis